CTOs on the Move

Careserve Inc

www.careserve.com

 
Careserve Inc is a Zanesville, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Giuseppe Space Enterprises

Giuseppe Space Enterprises is a company that specializes in the implementation, integration, and optimization of various tools and technologies into standardized system engineering/integration processes and workflows. They are committed to advancing th...

Lac St Anne County

Lac St Anne County is a Sangudo, AB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nava Health

Nava Health is a vertically integrated, tech-enabled healthcare practice that combines integrative, functional, preventive, and regenerative medicine to optimize health and increase longevity.

Revision Optics

ReVision Optics®, Inc., (RVO) is a privately held corporation headquartered in Southern California, USA. RVO`s main focus is developing unique optical solutions for the treatment of presbyopia. Fueled by a belief that no one should ever have to hold a menu out at arm`s length, the company developed the Raindrop® Near Vision Corneal Inlay, a unique patented refractive surgery solution. This inlay is designed to improve the near vision that has been lost by the eye`s natural aging process, called presbyopia. The Company is actively pursuing regulatory approvals and market opportunities for Raindrop® worldwide, and is committed to ridding the world of reading glasses, one satisfied patient at a time.

Fibrocell Science

Making an impact on rare and serious skin and connective tissue diseases Fibrocell Science is at the forefront of the exciting and promising field of personalized biologics. By extracting cells from skin to create localized therapies that are compatible with the unique biology of each patient, personalized biologics bring a transformational approach to drug development. It is Fibrocell’s scientific leadership and legacy in cultivating and harnessing autologous fibroblast cells that fuels its personalized biologics approach. Fibrocell’s proprietary technology uses a person’s own fibroblast cells – with or without genetic modification – to target localized treatment of rare and serious skin and connective tissue diseases.